Works matching AU Shi, Xinyu


Results: 142
    1
    2
    3
    4
    5

    Surprising magic of CD24 beyond cancer.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1334922
    By:
    • He Wang;
    • Peng Shi;
    • Xinyu Shi;
    • Yaqing Lv;
    • Hongwei Xie;
    • Hai Zhao
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2698, doi. 10.1002/alz.13735
    By:
    • Wang, Guoqiao;
    • Li, Yan;
    • Xiong, Chengjie;
    • Benzinger, Tammie L. S.;
    • Gordon, Brian A.;
    • Hassenstab, Jason;
    • Aschenbrenner, Andrew J.;
    • McDade, Eric;
    • Clifford, David B.;
    • Libre‐Guerra, Jorge J.;
    • Shi, Xinyu;
    • Mummery, Catherine J.;
    • van Dyck, Christopher H.;
    • Lah, James J.;
    • Honig, Lawrence S.;
    • Day, Gregg;
    • Ringman, John M.;
    • Brooks, William S.;
    • Fox, Nick C.;
    • Suzuki, Kazushi
    Publication type:
    Article
    13
    14
    16
    17
    18
    19
    20
    21

    Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2024, v. 81, n. 6, p. 582, doi. 10.1001/jamaneurol.2024.0991
    By:
    • Wagemann, Olivia;
    • Liu, Haiyan;
    • Wang, Guoqiao;
    • Shi, Xinyu;
    • Bittner, Tobias;
    • Scelsi, Marzia A.;
    • Farlow, Martin R.;
    • Clifford, David B.;
    • Supnet-Bell, Charlene;
    • Santacruz, Anna M.;
    • Aschenbrenner, Andrew J.;
    • Hassenstab, Jason J.;
    • Benzinger, Tammie L. S.;
    • Gordon, Brian A.;
    • Coalier, Kelley A.;
    • Cruchaga, Carlos;
    • Ibanez, Laura;
    • Perrin, Richard J.;
    • Xiong, Chengjie;
    • Li, Yan
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2669, doi. 10.1007/s00259-023-06209-0
    By:
    • Chen, Charles D.;
    • McCullough, Austin;
    • Gordon, Brian;
    • Joseph-Mathurin, Nelly;
    • Flores, Shaney;
    • McKay, Nicole S.;
    • Hobbs, Diana A.;
    • Hornbeck, Russ;
    • Fagan, Anne M.;
    • Cruchaga, Carlos;
    • Goate, Alison M.;
    • Perrin, Richard J.;
    • Wang, Guoqiao;
    • Li, Yan;
    • Shi, Xinyu;
    • Xiong, Chengjie;
    • Pontecorvo, Michael J.;
    • Klein, Gregory;
    • Su, Yi;
    • Klunk, William E.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50